Showing results (81-90 of 87) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|December 15, 2015
Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ InhibitorsYoungsook Shin, Julia Suchomel, Mario Cardozo, et al.Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.Bioorganic & Medicinal Chemistry|January 9, 2013
Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivityJoshua P Taygerly, Lawrence R McGee, Steven M Rubenstein, et al.Journal of Medicinal Chemistry|July 15, 2016
Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-Amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-N-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)Felix Gonzalez-Lopez de Turiso, Xiaolin Hao, Youngsook Shin, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogsTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.Bioorganic & Medicinal Chemistry Letters|November 16, 2010
A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hitTimothy D Cushing, Vijay Baichwal, Karen Berry, et al.Journal of Medicinal Chemistry|December 4, 2014
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune diseaseTimothy D Cushing, Xiaolin Hao, Youngsook Shin, et al.Pageof 9